These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 6160322

  • 1. Plasma concentrations and beta-blocking effects in normal volunteers after intravenous doses of metoprolol and propranolol.
    Regårdh CG, Johnsson G, Jordö L, Lungborg P, Persson BA, Rönn O.
    J Cardiovasc Pharmacol; 1980; 2(6):715-23. PubMed ID: 6160322
    [Abstract] [Full Text] [Related]

  • 2. The effects of propranolol, practolol and metoprolol on exercise-induced tachycardia in relation to plasma levels in man.
    Williams FM, Singh BN, Ambler PK, Dorrington R.
    Clin Exp Pharmacol Physiol; 1976; 3(5):473-82. PubMed ID: 975632
    [Abstract] [Full Text] [Related]

  • 3. The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta-adrenergic blocker on the response to dynamic exercise in normal men.
    Sklar J, Johnston GD, Overlie P, Gerber JG, Brammell HL, Gal J, Nies AS.
    Circulation; 1982 May; 65(5):894-9. PubMed ID: 7074750
    [Abstract] [Full Text] [Related]

  • 4. Selective and non-selective beta-blockade in renin release.
    Lammintausta R, Syvälahti E, Iisalo E, Kanto J, Mäntylä R.
    Acta Pharmacol Toxicol (Copenh); 1977 Nov; 41(5):489-96. PubMed ID: 202141
    [Abstract] [Full Text] [Related]

  • 5. Plasma levels and beta-blocking effect of alpha-hydroxymetoprolol--metabolite of metoprolol--in the dog.
    Regårdh CG, Ek L, Hoffmann KJ.
    J Pharmacokinet Biopharm; 1979 Oct; 7(5):471-9. PubMed ID: 43384
    [Abstract] [Full Text] [Related]

  • 6. Clinical pharmacology of a new beta-adrenoceptor blocking drug, befunolol. Cross-over comparison with propranolol on repeated administration.
    Ebihara A, Tawara K, Oka T, Ofuji T, Kawahara K.
    Eur J Clin Pharmacol; 1982 Oct; 23(3):189-95. PubMed ID: 6129139
    [Abstract] [Full Text] [Related]

  • 7. Comparison of four beta-blockers as assessed by 24-hour ECG recording.
    Escoubet B, Leclercq JF, Maison-Blanche P, Poirier JM, Gourmel B, Delhotal-Landes B, Coumel P.
    Clin Pharmacol Ther; 1986 Apr; 39(4):361-8. PubMed ID: 3956052
    [Abstract] [Full Text] [Related]

  • 8. Effect of atenolol, metoprolol, and propranolol on isoproterenol-induced tremor and tachycardia in normal subjects.
    Perucca E, Pickles H, Richens A.
    Clin Pharmacol Ther; 1981 Apr; 29(4):425-33. PubMed ID: 6258838
    [Abstract] [Full Text] [Related]

  • 9. Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man.
    Tattersfield AE, Cragg DJ, Bacon RJ.
    Br J Clin Pharmacol; 1984 Sep; 18(3):343-7. PubMed ID: 6148959
    [Abstract] [Full Text] [Related]

  • 10. Relevance of selectivity and non-selectivity in beta-adrenoceptor blocking drugs.
    Bonelli J.
    Br J Clin Pharmacol; 1982 Sep; 13(Suppl 2):199S-200S. PubMed ID: 6125170
    [Abstract] [Full Text] [Related]

  • 11. Assessment of metoprolol, a cardioselective beta-blocking agent, during chronic therapy in patients with angina pectoris.
    Borer JS, Comerford MB, Sowton E.
    J Int Med Res; 1976 Sep; 4(1):15-22. PubMed ID: 799974
    [Abstract] [Full Text] [Related]

  • 12. Extent of beta 1- and beta 2-receptor occupancy in plasma assesses the antagonist activity of metoprolol, pindolol, and propranolol in the elderly.
    Kaila T, Iisalo E, Lehtonen A, Saarimaa H.
    Cardiovasc Drugs Ther; 1993 Dec; 7(6):839-49. PubMed ID: 7912102
    [Abstract] [Full Text] [Related]

  • 13. Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol.
    Harron DW, Balnave K, Kinney CD, Wilson R, Russell CJ, Shanks RG.
    Clin Pharmacol Ther; 1981 Mar; 29(3):295-302. PubMed ID: 7471600
    [Abstract] [Full Text] [Related]

  • 14. Comparison of beta-adrenoceptor selectivity of acebutolol and its metabolite diacetolol with metoprolol and propranolol in normal man.
    Thomas MS, Tattersfield AE.
    Eur J Clin Pharmacol; 1986 Mar; 29(6):679-83. PubMed ID: 2872056
    [Abstract] [Full Text] [Related]

  • 15. Interaction of cimetidine with metoprolol, propranolol, or atenolol.
    Kirch W, Köhler H, Spahn H, Mutschler E.
    Lancet; 1981 Sep 05; 2(8245):531-2. PubMed ID: 6115283
    [No Abstract] [Full Text] [Related]

  • 16. Cardioselective (metoprolol) and non-selective (propranolol) beta-blockade and glucose homeostasis.
    Syvälahti E, Lammintausta R, Iisalo E, Kanto J.
    Ann Clin Res; 1977 Oct 05; 9(5):292-5. PubMed ID: 616215
    [Abstract] [Full Text] [Related]

  • 17. Lidocaine elimination: effects of metoprolol and of propranolol.
    Conrad KA, Byers JM, Finley PR, Burnham L.
    Clin Pharmacol Ther; 1983 Feb 05; 33(2):133-8. PubMed ID: 6822025
    [Abstract] [Full Text] [Related]

  • 18. Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine.
    Kirch W, Spahn H, Köhler H, Ohnhaus EE, Mutschler E.
    Klin Wochenschr; 1982 Nov 15; 60(22):1401-7. PubMed ID: 7176462
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the inotropic and chronotropic effects of metoprolol and propranolol.
    Conrad KA.
    J Clin Pharmacol; 1981 Nov 15; 21(5-6):213-8. PubMed ID: 7263914
    [Abstract] [Full Text] [Related]

  • 20. Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.
    Leopold G, Ungethüm W, Pabst J, Simane Z, Bühring KU, Wiemann H.
    Br J Clin Pharmacol; 1986 Sep 15; 22(3):293-300. PubMed ID: 2876722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.